Seascape Capital Management Pfizer Inc Transaction History

Seascape Capital Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$41.75 - $54.5 $68,595 - $89,543	-1,643 Reduced 18.01%	7,480 $383,000
Q3 2022 Nov 08, 2022	SELL	$43.76 - $53.42 $25,074 - $30,609	-573 Reduced 5.91%	9,123 $399,000
Q2 2022 Aug 09, 2022	BUY	$46.53 - $55.17 $241,397 - $286,221	5,188 Added 115.08%	9,696 $508,000
Q1 2022 May 09, 2022	BUY	$45.75 - $56.69 $3,751 - $4,648	82 Added 1.85%	4,508 $233,000
Q4 2021 Jan 27, 2022	BUY	$41.32 - $61.25 $182,882 - $271,092	4,426 New	4,426 $261,000
Q2 2020 Aug 11, 2020	SELL	$30.12 - $36.54 $354,542 - $430,112	-11,771 Closed	0 $0
Q1 2020 May 28, 2020	BUY	$27.03 - $38.62 $170,289 - $243,305	6,300 Added 115.15%	11,771 $384,000
Q4 2019 Feb 13, 2020	BUY	$32.92 - $37.36 $180,105 - $204,396	5,471 New	5,471 $214,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Seascape Capital Management, based on Form 13F filings with the SEC.

Stay updated on Seascape Capital Management with notifications on news.